Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06275074 · ClinicalTrials.gov registry record · NA
Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance
A NA study of Sleep Disturbance and Neck Pain, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06275074: Active NA study of Sleep Disturbance and Neck Pain, sponsored by Mayo Clinic.
NCT06275074 is a NA study of Sleep Disturbance and Neck Pain that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 177-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06275074, a NA study of Sleep Disturbance and Neck Pain, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Feasibility study investigating the effects of dry needling on individuals with chronic neck pain and sleep disturbance.
Primary Outcome
One variable to be assessed to determine feasibility is retention rate of participants recruited and enrolled. The retention rate of participants will be calculated as follows: Retention rate = (Number of patients completing the study / Number of patients initially enrolled) x 100. Feasibility will be determined with 4-week attrition rate is less than 20%
Conditions Studied
Interventions
- PROCEDURE Dry Needling
- OTHER Therapeutic Exercise
Study Locations (1)
Minnesota
- Mayo Clinic - Motion Analysis Lab - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the registry record for NCT06275074 still lists
NCT06275074 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 177-participant average among 56 other Sleep Disturbance trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Sleep Disturbance appearing as the primary indexed condition, and to 2 interventions - of which Dry Needling is the first listed.
NCT06275074 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06275074 about?
NCT06275074 is a clinical study titled "Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance". Feasibility study investigating the effects of dry needling on individuals with chronic neck pain and sleep disturbance.
What is the current status of trial NCT06275074?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2024-03-14. Estimated completion is 2026-03-01.
What conditions does trial NCT06275074 study?
This clinical trial studies the following conditions: Sleep Disturbance, Neck Pain.
What interventions are being tested in trial NCT06275074?
The interventions under investigation include: Dry Needling (PROCEDURE), Therapeutic Exercise (OTHER).
Who is sponsoring clinical trial NCT06275074?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06275074 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disturbance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06275074's enrollment target sits among peer trials
28 50th of 56 higher than 7 of 56 other Sleep Disturbance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disturbance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adjunctive Bright Light Therapy for Opioid Use Disorder
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia
RECRUITING · NA
-
Sleep Promotion Program Primary Care
RECRUITING · NA
-
VR-PMR for Post-Burn Symptoms
RECRUITING · NA
-
SPARK Healthy Sleep
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI